We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+6.57%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$49.1B
AUM Growth
+$4.31B
Cap. Flow
+$1.72B
Cap. Flow %
3.51%
Top 10 Hldgs %
14.46%
Holding
3,114
New
67
Increased
2,155
Reduced
468
Closed
57

Sector Composition

Rank Sector Weight
1 Financials 14.36%
2 Healthcare 13.62%
3 Technology 13.02%
4 Industrials 11.1%
5 Energy 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXDX
2926
DELISTED
Accelerate Diagnostics
AXDX
$193K ﹤0.01%
1,480
SNAK
2927
DELISTED
Inventure Foods, Inc.
SNAK
$193K ﹤0.01%
17,900
FSGI
2928
DELISTED
FIRST SECURITY GROUP, INC.
FSGI
$193K ﹤0.01%
89,000
STCN
2929
DELISTED
Steel Connect, Inc. Common Stock
STCN
$192K ﹤0.01%
7,409
NPTN
2930
DELISTED
NEOPHOTONICS CORP
NPTN
$192K ﹤0.01%
26,800
MNTX
2931
DELISTED
Manitex International, Inc.
MNTX
$192K ﹤0.01%
17,500
TRR
2932
DELISTED
Trc Companies
TRR
$191K ﹤0.01%
27,050
NEON icon
2933
Neonode
NEON
$16.3M
$190K ﹤0.01%
3,090
CUTR
2934
DELISTED
Cutera, Inc.
CUTR
$190K ﹤0.01%
20,900
FRTX
2935
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$190K ﹤0.01%
47
-14
-23% -$105K
TLRA
2936
DELISTED
Telaria, Inc.
TLRA
$190K ﹤0.01%
+19,727
New +$161K
CFNB
2937
DELISTED
California First National Banc
CFNB
$189K ﹤0.01%
+11,100
New +$184K
LCUT icon
2938
Lifetime Brands
LCUT
$213M
$188K ﹤0.01%
12,400
SIGA icon
2939
SIGA Technologies
SIGA
$210M
$188K ﹤0.01%
46,100
HALL
2940
DELISTED
Hallmark Financial Services, Inc.
HALL
$188K ﹤0.01%
2,120
BREW
2941
DELISTED
Craft Brew Alliance, Inc.
BREW
$188K ﹤0.01%
13,900
OMED
2942
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$188K ﹤0.01%
+11,885
New +$220K
SPDC
2943
DELISTED
SPEED COMMERCE, INC COM STK
SPDC
$187K ﹤0.01%
57,100
CNSY
2944
Cerenome, Inc. Common Stock
CNSY
$26.4M
0
ENZ
2945
DELISTED
Enzo Biochem, Inc.
ENZ
$185K ﹤0.01%
73,641
-5,140
-7% -$12.2K
FRO icon
2946
Frontline
FRO
$8.56B
$184K ﹤0.01%
13,800
SCMP
2947
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$184K ﹤0.01%
29,400
MDW
2948
DELISTED
MIDWAY GOLD CORP (CANADA)
MDW
$184K ﹤0.01%
186,800
BCRX icon
2949
BioCryst Pharmaceuticals
BCRX
$2.51B
$182K ﹤0.01%
23,900
GMAN
2950
DELISTED
Gordmans Stores, Inc.
GMAN
$182K ﹤0.01%
16,022
-1,733
-10% -$24.1K

Similar funds

Charles Schwab's Q3 2013 Portfolio in Review

As of Q3 2013, Charles Schwab held 3,114 positions worth $49.1B, up 9.6% from $44.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab deployed $1.72B of net new capital in Q3 2013, opening 67 new positions and adding to 2,155 existing holdings. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 4,003,512 shares worth $136M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Merck, an estimated $76M trimmed.

  • Charles Schwab's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 4,003,512 shares worth $136M.
  • Charles Schwab added most to Johnson & Johnson in Q3 2013, an estimated $125M increase.
  • Charles Schwab's biggest Q3 2013 reduction was Merck, cutting an estimated $76M.
  • Charles Schwab fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $47.2M.
  • Charles Schwab's ten largest holdings make up 14% of its $49.1B portfolio in Q3 2013.
  • Charles Schwab opened 67 new positions and closed 57 in Q3 2013.
  • Charles Schwab's portfolio value rose 9.6% quarter-over-quarter to $49.1B.

Based on Charles Schwab's 13F filing for Q3 2013, filed 14 Nov 2013.